Archive for the ‘homeslider’

Registration Open for Specialist Hormonal Migraine in Women Seminar

8th February 2018

As part of Brain Awareness Week 2018 (March 5th - 11th), we are delighted to announce a Specialist Seminar on Hormonal Migraine in Women which will take place on International Women's Day, March 8th 2018. Many migraines in women can be triggered by hormonal changes in the body at various stages of their reproductive lives. This seminar will explain why and how hormonal migraines occur and what medical and nutritional options can help... [read more]


Research study on migraine and light sensitivity.

29th January 2018

If you have a diagnosis of migraine you may be interested in participating in a study being carried out through NUI Galway Psychology Department as part of a doctoral qualification. The researchers are interested in investigating the impact of light sensitivity (photo-phobia) on everyday lifestyle in people who experience migraine. If you are interested in participating in the study, or simply in finding out more about it, you can do so at... [read more]


Reasonable Accommodation for State Exams 2018 – Late Applications

18th January 2018

The late application forms for Reasonable Accommodations (RACE) for the 2018 Leaving Certificate have now been issued. Details are below. The closing date for the Reasonable Accommodations for the 2018 State Exams was 27th of October 2017, however, there is still a chance to apply. The closing date for late applications is March 23rd 2018 The SEC has issued two guides to make people aware of the changes that have been made to the... [read more]


New Preventative Drugs for Migraine

6th December 2017

Calcitonin gene-related receptor (CGRP) antagonists are the most important medications in advanced stage clinical development for the treatment of both the acute migraine attack and the prevention of frequent attacks. Clinical trials on two of the antibodies have now been published in the New England Journal of Medicine. One antibody, Erenumab made by Novartis, was trialed on 955 patients with episodic migraine. At the start of the... [read more]


Worldwide Burden of Migraine Patient Survey

8th November 2017

We are supporting the Worldwide Burden of Migraine Patient survey, a global survey by Novartis in association with the European Headache Alliance (EHA). EHA is a not for profit European umbrella organization for migraine and headache patient groups in Europe.   The survey aims to increase awareness and understanding of the effect migraine has on the lives of those who suffer from the disease.  Your story will be contributing... [read more]


Archive for the ‘homeslider’

Registration Open for Specialist Hormonal Migraine in Women Seminar

8th February 2018

As part of Brain Awareness Week 2018 (March 5th - 11th), we are delighted to announce a Specialist Seminar on Hormonal Migraine in Women which will take place on International Women's Day, March 8th 2018. Many migraines in women can be triggered by hormonal changes in the body at various stages of their reproductive lives. This seminar will explain why and how hormonal migraines occur and what medical and nutritional options can help... [read more]


Research study on migraine and light sensitivity.

29th January 2018

If you have a diagnosis of migraine you may be interested in participating in a study being carried out through NUI Galway Psychology Department as part of a doctoral qualification. The researchers are interested in investigating the impact of light sensitivity (photo-phobia) on everyday lifestyle in people who experience migraine. If you are interested in participating in the study, or simply in finding out more about it, you can do so at... [read more]


Reasonable Accommodation for State Exams 2018 – Late Applications

18th January 2018

The late application forms for Reasonable Accommodations (RACE) for the 2018 Leaving Certificate have now been issued. Details are below. The closing date for the Reasonable Accommodations for the 2018 State Exams was 27th of October 2017, however, there is still a chance to apply. The closing date for late applications is March 23rd 2018 The SEC has issued two guides to make people aware of the changes that have been made to the... [read more]


New Preventative Drugs for Migraine

6th December 2017

Calcitonin gene-related receptor (CGRP) antagonists are the most important medications in advanced stage clinical development for the treatment of both the acute migraine attack and the prevention of frequent attacks. Clinical trials on two of the antibodies have now been published in the New England Journal of Medicine. One antibody, Erenumab made by Novartis, was trialed on 955 patients with episodic migraine. At the start of the... [read more]


Worldwide Burden of Migraine Patient Survey

8th November 2017

We are supporting the Worldwide Burden of Migraine Patient survey, a global survey by Novartis in association with the European Headache Alliance (EHA). EHA is a not for profit European umbrella organization for migraine and headache patient groups in Europe.   The survey aims to increase awareness and understanding of the effect migraine has on the lives of those who suffer from the disease.  Your story will be contributing... [read more]